Timothy Kelly

Timothy Kelly

Directeur Technique/Scientifique/R&D chez ABIVAX

Fortune : 112 613 $ au 31/08/2026

57 ans
Health Technology
Consumer Services
Producer Manufacturing

Profil

Mr. Timothy P.
Kelly
is a Chief Technical Officer at Abivax SA. Mr. Kelly was previously employed as a Chief Technology Officer by Caribou Biosciences, Inc., a Chairman & Chief Executive Officer by Oxford Biomedica Solutions LLC, a Chief Operating Officer by Homology Medicines, Inc., a Head-Technical Operations by Sarepta Therapeutics, Inc., a Head-Technical Operations by Shire Plc, a Head-Technical Operations by UCB SA, and a Senior Director-International Operations by Biogen Idec, Inc. He received his undergraduate degree from United States Air Force Academy and an MBA from Troy University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
25/02/2026 73 125 ( 0,07 % ) 112 613 $ 31/08/2026

Postes actifs de Timothy Kelly

SociétésPosteDébut
ABIVAX Directeur Technique/Scientifique/R&D 21/09/2026

Anciens postes connus de Timothy Kelly

SociétésPosteFin
Directeur Général 01/07/2023
Q32 BIO INC. Directeur des opérations 10/03/2022
SAREPTA THERAPEUTICS, INC. Corporate Officer/Principal 01/05/2017
SHIRE Corporate Officer/Principal 01/01/2017
UCB Corporate Officer/Principal 01/01/2009
Voir l'expérience en détail de Timothy Kelly

Formation de Timothy Kelly

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

74

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Producer Manufacturing

  1. Bourse
  2. Insiders
  3. Timothy Kelly
🔇